Rocket Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RTW INVESTMENTS, LP | 02/14/2025 | 17.69 M | $222.34 M | 0.00% | 18.79% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 14.00 M | $175.92 M | 24.49% | 14.86% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 7.10 M | $89.21 M | 11.40% | 7.54% |
VANGUARD GROUP INC | 02/11/2025 | 6.58 M | $82.68 M | 18.79% | 6.99% |
MAVERICK CAPITAL LTD | 02/14/2025 | 5.20 M | $65.35 M | 26.23% | 5.52% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 02/11/2025 | 4.71 M | $59.26 M | 4.91% | 5.01% |
JANUS HENDERSON GROUP PLC | 02/14/2025 | 4.00 M | $50.34 M | 111.03% | 4.25% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 3.15 M | $39.58 M | -1.85% | 3.34% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 2.57 M | $32.27 M | 100.00% | 2.73% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.75 M | $22.04 M | 8.35% | 1.86% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 1.57 M | $19.73 M | 3,163.94% | 1.67% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 1.48 M | $18.59 M | -0.44% | 1.57% |
02/14/2025 | 1.47 M | $18.43 M | 100.00% | 1.56% | |
PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 1.32 M | $16.57 M | -4.96% | 1.40% |
AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 1.20 M | $15.08 M | 100.00% | 1.27% |
TORONTO DOMINION BANK | 02/19/2025 | 1.10 M | $13.83 M | 100.00% | 1.17% |
NOVO HOLDINGS A/S | 02/14/2025 | 1.10 M | $13.83 M | 0.00% | 1.17% |
PROSIGHT MANAGEMENT, LP | 02/14/2025 | 1.09 M | $13.69 M | 583.14% | 1.16% |
AVIDITY PARTNERS MANAGEMENT LP | 02/14/2025 | 1.05 M | $13.24 M | 40.63% | 1.12% |
BIOIMPACT CAPITAL LLC | 02/14/2025 | 1.02 M | $12.83 M | -4.30% | 1.08% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 802,785 | $10.09 M | 89.30% | 0.85% |
RUSSELL INVESTMENTS GROUP, LTD. | 02/13/2025 | 791,877 | $9.95 M | -2.52% | 0.84% |
EVENTIDE ASSET MANAGEMENT, LLC | 02/14/2025 | 770,691 | $9.69 M | 0.00% | 0.82% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 760,941 | $9.56 M | -16.62% | 0.81% |
TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 750,000 | $9.43 M | 0.00% | 0.80% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 656,090 | $8.25 M | 15.14% | 0.70% |
FRANKLIN RESOURCES INC | 02/12/2025 | 653,559 | $8.22 M | -62.23% | 0.69% |
WOODLINE PARTNERS LP | 02/14/2025 | 652,421 | $8.20 M | 8.54% | 0.69% |
SIREN, L.L.C. | 02/14/2025 | 600,000 | $7.54 M | 100.00% | 0.64% |
UBS GROUP AG | 02/14/2025 | 569,963 | $7.16 M | 68.56% | 0.61% |
JPMORGAN CHASE & CO | 02/12/2025 | 515,528 | $6.48 M | -7.37% | 0.55% |
MARSHALL WACE, LLP | 02/13/2025 | 456,762 | $5.74 M | 4,422.40% | 0.49% |
VOSS CAPITAL, LLC | 02/13/2025 | 421,700 | $5.30 M | 100.00% | 0.45% |
SCHRODER INVESTMENT MANAGEMENT GROUP | 02/12/2025 | 413,550 | $4.98 M | 75.98% | 0.44% |
PRIVIUM FUND MANAGEMENT B.V. | 02/11/2025 | 397,650 | $5.00 M | 34.89% | 0.42% |
M28 CAPITAL MANAGEMENT LP | 02/13/2025 | 385,680 | $4.85 M | 0.00% | 0.41% |
PERCEPTIVE ADVISORS LLC | 02/14/2025 | 378,584 | $4.76 M | -59.37% | 0.40% |
INVESCO LTD. | 02/13/2025 | 357,840 | $4.50 M | 1.48% | 0.38% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 336,909 | $4.23 M | -71.98% | 0.36% |
SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 271,792 | $3.42 M | 17.26% | 0.29% |
SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 271,659 | $3.41 M | 100.00% | 0.29% |
STEMPOINT CAPITAL LP | 02/14/2025 | 270,983 | $3.41 M | 100.00% | 0.29% |
HENNION & WALSH ASSET MANAGEMENT, INC. | 01/15/2025 | 237,499 | $2.99 M | 7.44% | 0.25% |
BARCLAYS PLC | 02/13/2025 | 233,952 | $2.94 M | 50.96% | 0.25% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 221,911 | $2.79 M | 12.59% | 0.24% |
WALLEYE CAPITAL LLC | 02/13/2025 | 220,142 | $2.77 M | 59.06% | 0.23% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 218,519 | $2.75 M | 100.00% | 0.23% |
ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 211,400 | $2.66 M | 4,816.28% | 0.22% |
OVATA CAPITAL MANAGEMENT LTD | 02/13/2025 | 200,000 | $2.51 M | 100.00% | 0.21% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 194,182 | $2.44 M | 5.40% | 0.21% |
Rocket Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 262 institutional investors and hedge funds held shares of Rocket Pharmaceuticals, Inc.. The most heavily invested institutionals were:
RTW INVESTMENTS, LP: 17.69 M
WELLINGTON MANAGEMENT GROUP LLP: 14 M
BlackRock Funding, Inc. /DE: 7.1 M
VANGUARD GROUP INC: 6.58 M
MAVERICK CAPITAL LTD: 5.2 M
WESTFIELD CAPITAL MANAGEMENT CO LP: 4.71 M
116.45% of Rocket Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 248.68 M shares in the last 24 months. This purchase volume represents approximately $3.07 B in transactions.